Single-use Assemblies Market

Global Single-use Assemblies Market Size (2023 to 2028)

The global market size for single-use assemblies is estimated to grow at a CAGR of 28.99% from 2023 to 2028. The market was valued at USD 3.68 billion in 2023 and is forecasted to be USD 13.17 billion by 2028.

A single-use assembly is a piece of process equipment used to manufacture pharmaceuticals and biologics, and it has numerous advantages, including reduced utility requirements, cheaper energy costs, less water and chemical use, and industrial flexibility. It is frequently used in bioprocessing and the pharmaceutical industry. Bioprocess bags, bioreactors, containers, and mixers are among the products included. End-users benefit from single-use assemblies because they save time, money, and labor. Cross-contamination and leakage are also less likely.

Impact of COVID-19 on the global single-use assemblies market:

COVID-19 substantially impacts the single-use assemblies market, as single-use technology is increasingly being used for research in COVID-19 vaccine development. Many businesses are working on R&D operations to create a vaccine that requires single-use assemblies. Suppliers are trying to keep up with demand during the pandemic, causing single-use assemblies to expand in popularity. In addition, commonly used drugs such as hydroxychloroquine have seen a considerable surge in demand for COVID-19 treatment. Because many wealthy countries are running out of these treatments, the growing demand has presented a significant opportunity for COVID-19 management drug producers. As a result of the demand for COVID-19 vaccines and treatment drugs, the pharmaceutical and biotechnology sectors are expected to grow dramatically. As a result, during the pandemic, the market has developed positively.

MARKET DRIVERS:

The key advantages of single-use technologies over traditional stainless-steel assemblies, such as rapid deployment and reduced danger of cross-contamination drive the single-use assemblies market growth.

The market is also being driven by rising biopharmaceutical R&D spending and a growing biologics market. These benefits include a shorter bioprocess cycle deployment of single-use assembly components and a lesser risk of cross-contamination. In addition, single-use assemblies are ergonomically designed to hold integrated single-use flow channels for quicker setup and less space. However, preparation, set-up, testing, validation, and documentation take time and money, and the product design aims to cut down on those costs. Furthermore, the single-use assembly market is experiencing significant growth due to an expansion in client base, increased R&D activities at the academic and industrial levels, and increased demand for biomedical applications.

To reduce the danger of contamination and increase operative effectiveness, the bioprocessing business is rapidly shifting toward single-use assembly methods. Single-use technologies, including single-use bioprocessing equipment, have evolved as powerful and expandable solutions ranging from lab/scale-up to cGMP production applications. The market is predicted to grow faster due to the benefits and qualities of single-use products, such as cost-effectiveness and eliminating of clean-in-place regulations due to their disposable nature. Furthermore, single-use assemblies are predicted to rise significantly due to increasing public-private support for single-use assembly operations and the ease of developing bioprocessing equipment. Over the next few years, rising demand for generic drugs and biosimilars will likely drive up demand for single-use bodies.

MARKET RESTRAINTS:

The majority of biopharmaceutical processes operate at high temperatures, resulting in the production of unneeded and unknown compounds that could compromise the final product. As a result, issues about extractable and leachable from single-use assembly components may impede their use in the coming years. In addition, solid waste generated by single-use assemblies poses several challenges for biomanufacturing enterprises, including solid waste disposal and increased waste management expenses.

REPORT COVERAGE:

This research report on the global single-use assemblies market has been segmented and sub-segmented based on product, application, end-user & region.

Single-Use Assemblies Market – By Product:

• Bag Assemblies
• Filtration Assemblies
• Bottle Assemblies
• Mixing System Assemblies

The bag assemblies segment had the most significant share of the global single-use assemblies market in 2022. Buffers and media preparation, cell culture, harvest & intermediate collection, sampling, freezing & thawing, and storage & transport are applications for single-use bag assemblies in bioprocesses. They allow for crucial liquid handling in biomanufacturing while also removing the time and cost of additional cleaning-in-place and sterilization-in-place (CIP/SIP) system setup, maintenance, and validation.

Single-Use Assemblies Market – By Application:

• Filtration
• Cell Culture & Mixing
• Storage
• Sampling
• Fill-finish Applications

The filtering segment held the highest share of the single-use assembly market in 2022. Because of its advantages in this application, such as simplicity of column cleaning, sterilization, packing, and more accessible validation and cleaning, single-use assemblies for filtration are rapidly becoming more popular.

Single-Use Assemblies Market – By End-User:

• Biopharmaceutical & Pharmaceutical Companies
• CROs & CMOs
• Academic & Research Institutes

The segment of biopharmaceutical and pharmaceutical companies held the highest share of the single-use assembly market in 2022. The elderly are more susceptible to disorders treated with biologics, driving demand for biopharmaceuticals. As a result, biopharmaceutical companies concentrate their efforts on producing low-cost biologics. Single-use assemblies are becoming more popular as the production of biologics and biosimilars grows. They offer a wide range of applications in each stage of the manufacturing process.

Single-Use Assemblies Market – By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

North America had the highest share of the global market for single-use assemblies. The region's substantial market share can be ascribed to its well-established biopharmaceutical industry, extensive availability of single-use assemblies offered by regional market players, and rising biologics and biosimilar manufacturing. The United States is the world's largest pharmaceutical market, accounting for nearly a third of global sales, and the world's leader in biopharmaceutical research and development, according to the International Trade Administration (ITA), which the United States Department of Commerce manages to promote and facilitate business investment in the United States.

The APAC market is predicted to develop at the fastest rate during the forecast period. This is due to the expanding biopharmaceutical market and manufacturing capacities in Asian countries, increased life science research activities, increased investments by pharmaceutical and biotechnology businesses, and the expansion of the contract R&D sector.

KEY MARKET PARTICIPANTS:

Sartorius AG, Thermo Fisher Scientific, Pall Corporation, Merck KGaA, Avantor, Inc., Saint-Gobain Performance Plastics, PARKER HANNIFIN CORP, Corning Incorporated, and Repligen Corporation are some of the companies playing a promising role in the global single-use assemblies market profiled in this report.

RECENT HAPPENINGS IN THIS MARKET:

• Pall Corporation, a global leader in filtration, separation, and purification, partnered with Broadley-James Corporation, a recognized sensor technology provider, to integrate and distribute Broadley-James' advanced single-use probe and flow cell pH sensors 2019.
• With a new manufacturing facility in Spartanburg County, South Carolina, and the shareholder acquisition of Pall-Austar Lifesciences Limited, a China-based joint-venture, Pall Corporation, a global leader in filtration, separation, and purification, continues to increase its capacity to meet industry demands driven by COVID-19 in 2021.